药品报销目录应考虑临床治疗指标(Clinical Indicators)对医疗卫生支出的影响(Budget Impact),药物经济学性价比(Cost-Effectiveness)和生命质量指数(Quality of Life)。澳大利亚是世界上率先实行药品报销的药物经济性评价制度的国家。...药品报销目录应考虑临床治疗指标(Clinical Indicators)对医疗卫生支出的影响(Budget Impact),药物经济学性价比(Cost-Effectiveness)和生命质量指数(Quality of Life)。澳大利亚是世界上率先实行药品报销的药物经济性评价制度的国家。随后瑞士、加拿大安大略省和美国的一些私人保险公司也紧跟着实行了药品报销的药物经济性评价制度。近年来,多数欧洲国家和一些亚洲国家,如日本、韩国也相继实行了药品报销的药物经济性评价制度。此制度是有效控制药品费用的重要方法之一。展开更多
The aim of this literature review was to summarize available findings from publications that reported expenditure on traditional/complementary and alternative medicine(TM/CAM)within a representative general population...The aim of this literature review was to summarize available findings from publications that reported expenditure on traditional/complementary and alternative medicine(TM/CAM)within a representative general population sample of a nation or a defined geographical area.A total of 24 publications met the inclusion criteria and were included in the review.The expenditure on TM/CAM varies worldwide,but direct comparison of the findings of publications included in this review is limited due to the differences in the definitions of TM/CAM,inclusion of various forms of TM/CAM,use of different names and categorization,as well as differences in reported currencies and time periods in which data were collected.Data about the expenditure on TM/CAM in most countries throughout the world are scarce.Further national studies should be conducted in order to provide up-to-date assessment of the TM/CAM related expenditure patterns and use.Uniform nomenclature,definition of TM/CAM and standardized instruments would provide basis for comparability of data of studies conducted in various regions and time periods.展开更多
文摘药品报销目录应考虑临床治疗指标(Clinical Indicators)对医疗卫生支出的影响(Budget Impact),药物经济学性价比(Cost-Effectiveness)和生命质量指数(Quality of Life)。澳大利亚是世界上率先实行药品报销的药物经济性评价制度的国家。随后瑞士、加拿大安大略省和美国的一些私人保险公司也紧跟着实行了药品报销的药物经济性评价制度。近年来,多数欧洲国家和一些亚洲国家,如日本、韩国也相继实行了药品报销的药物经济性评价制度。此制度是有效控制药品费用的重要方法之一。
文摘The aim of this literature review was to summarize available findings from publications that reported expenditure on traditional/complementary and alternative medicine(TM/CAM)within a representative general population sample of a nation or a defined geographical area.A total of 24 publications met the inclusion criteria and were included in the review.The expenditure on TM/CAM varies worldwide,but direct comparison of the findings of publications included in this review is limited due to the differences in the definitions of TM/CAM,inclusion of various forms of TM/CAM,use of different names and categorization,as well as differences in reported currencies and time periods in which data were collected.Data about the expenditure on TM/CAM in most countries throughout the world are scarce.Further national studies should be conducted in order to provide up-to-date assessment of the TM/CAM related expenditure patterns and use.Uniform nomenclature,definition of TM/CAM and standardized instruments would provide basis for comparability of data of studies conducted in various regions and time periods.
